Results 71 to 80 of about 87,239 (208)

Subgroup analysis of OS stratified by adjuvant radiotherapy and chemoradiotherapy.

, 2020
A, adjuvant radiotherapy; B, adjuvant chemoradiotherapy.
Lei Wang (6656), Nanping Lin (8478612), Manjun Deng (8478615), Qiao Ke (8478609), Jingfeng Liu (1392460), Yongyi Zeng (1392457)   +5 more
core   +1 more source

Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial [PDF]

BACKGROUND: Locally advanced cervical cancer is treated with chemoradiotherapy (standard of care), but many patients still relapse and die from metastatic disease.
Persic, Mojca, Stobart, Hilary, Whitmarsh, Karen, Eminowicz, Gemma, Farrelly, Laura, Reed, Nicholas, Drake, Anne, Forrest, Jennifer, Panades, Miguel, Mukhopadhyay, Asima, Mak, Choi, Adusumalli, Madhavi, Hudson, Emma, Alamilla-Garcia, Gabriela, Gallardo, Dolores, Chavez-Blanco, Adriana, King, Margaret, Diez, Patricia, Anand, Anjana, Bhana, Rajanee, Colombo, Nicoletta, Kent, Christopher, Hackshaw, Allan, Hacker, Anne-Marie, McGrane, John, Ledermann, Jonathan Andrew, Mandal, Ranajit, Chowdhury, Rahul Roy, McCormack, Mary, Feeney, Amanda, Mathew, Tony, Vaja, Simran   +31 more
core   +2 more sources

Temozolomide Chemoradiotherapy and Pneumocystis Pneumonia Prophylaxis

, 2022
Background: Pneumocystis pneumonia (PCP) can occur in glioma patients receiving chemoradiotherapy. Health Canada recommends PCP prophylaxis during temozolomide chemoradiotherapy. Not all neuro-oncologists follow these recommendations.
Climans, Seth Andrew
core  

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy

Gastroenterology Research and Practice, 2013
Background. Little data on directly comparing chemoradiotherapy with observation has yet been published in the setting of adjuvant therapy for resected gastric cancer who underwent D2 lymphadenectomy.
Qiong Yang, Ying Wei, Yan-Xian Chen, Si-Wei Zhou, Zhi-Min Jiang, De-Rong Xie   +5 more
doaj   +1 more source

Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma

Chuanfeng Zhang, Zhen Guo, Zhao Jing Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang, 310013, People’s Republic of ChinaCorrespondence: Zhao Jing, Department of Oncology, Zhejiang Hospital, No.
Jing Z, Guo Z, Zhang C
core  

Kaplan-Meier estimates of relapse-free survival and disease-free survival for patients receiving Neoadjuvant-concurrent chemoradiotherapy versus Concurrent chemoradiotherapy versus IMRT alone.

, 2013
Kaplan-Meier estimates of relapse-free survival and disease-free survival for patients receiving Neoadjuvant-concurrent chemoradiotherapy versus Concurrent chemoradiotherapy versus IMRT alone.
Yajuan Zhou (282972), Xia Fan (282967), Xuemei Ji (282962), Desheng Hu (282965), Conghua Xie (282964), Yingjie Zheng (282977)   +5 more
core   +1 more source

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

, 2012
Background The effect of the addition of adjuvant chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma is unclear.
Sun, Ying, Mao, Yan-Ping, Guo, Ying, Wei-Xiong Li, Guo-Xian Long, Zheng, Bao-Min, Ting-Ting Xu, Sun, Yan, Chao-Su Hu, Bao-Min Zheng, Ying Guo, Chen, Xiao-Zhong, Long, Guo-Xian, Guo-Qing Hu, Ying Sun, Hu, Chao-Su, Zhi-Bin Cheng, Xiao-Zhong Chen, Chen, Yong, Yu-Ming Chen, Hu, Guo-Qing, Shao-Bo Liang, Liang, Shao-Bo, Lei Chen, Meng-Zhong Liu, Yuan-Yuan Chen, Xu, Ting-Ting, Wang, Si-Yang, Chen, Lei, Yan-Ping Mao, Si-Yang Wang, Li, Wei-Xiong, Liu, Meng-Zhong, Bin Li, Xie, Fang-Yun, Cheng, Zhi-Bin, Li, Bin, Ling-Long Tang, Jun Ma, Ma, Jun, Fang-Yun Xie, Chen, Yu-Ming, Yan Sun, Chen, Yuan-Yuan, Tang, Ling-Long, Yong Chen   +45 more
core   +1 more source

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma

Cancer Management and Research, 2019
Katsuyuki Sakanaka,1 Kota Fujii,1 Yuichi Ishida,1 Shin’ichi Miyamoto,2 Takahiro Horimatsu,3 Manabu Muto,3 Takashi Mizowaki11Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan ...
Sakanaka K, Fujii K, Ishida Y, Miyamoto S, Horimatsu T, Muto M, Mizowaki T   +6 more
doaj  

Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer

, 2007
OBJECTIVE: \ud We present and analyze long-term outcomes following multimodal therapy for esophageal cancer, in particular the relative impact of histomorphologic tumor regression and nodal status.
Ravi, Naraymasamy, Kennedy, John, Rowley, Suzanne, O'Byrne, Kenneth J., Murphy, Thomas J., Hollywood, Donal, Muldoon, Cian, Reynolds, John V.   +7 more
core   +1 more source

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction

, 2015
ObjectiveThis study was conducted to investigate the efficacy and safety of using a concurrent neoadjuvant chemoradiotherapy (a XELOX regimen) to treat adenocarcinoma of the gastroesophageal junction.MethodsSeventy-six patients having resectable ...
Shi, Gaofeng, Zhao, Qun, Tan, Bibo, Tian, Yuan, Liu, Yueping, Yang, Peigang, Li, Yong, Xu, Qian, Li, Ruxun, Qiao, Xueying, Wang, Jun, Zhang, Jun   +11 more
core   +1 more source